Neurobiology of Aging
Volume 30, Issue 9 , Pages 1430-1443 , September 2009

Progressive impairment in olfactory working memory in a mouse model of Mild Cognitive Impairment

  • Jared W. Young

      Affiliations

    • Present address: Department of Psychiatry, UCSD, 9500 Gilman Drive, La Jolla 92093-0804, USA.
    • ,
  • John Sharkey

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +44 131 650 8491; fax: +44 131 667 9381.
    • ,
  • Keith Finlayson

      Affiliations

    • Present address: Centre for Chemical and Translational Biology, The University of Edinburgh, Darwin Building, The King's Buildings, Edinburgh EH9 3JJ UK.

Received 9 August 2007 ,Revised 25 October 2007 ,Accepted 17 November 2007.

References 

  1. Apelt J, Kumar A, Schliebs R. Impairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the Swedish mutation of human beta-amyloid precursor protein. Brain Res. 2002;953:17–30
  2. Arendash GW, King DL. Intra- and intertask relationships in a behavioral test battery given to Tg2576 transgenic mice and controls. Physiol. Behav. 2002;75:643–652
  3. Arendash GW, King DL, Gordon MN, Morgan D, Hatcher JM, Hope CE, et al. Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res. 2001;891:42–53
  4. Arendash GW, Garcia MF, Costa DA, Cracchiolo JR, Wefes IM, Potter H. Environmental enrichment improves cognition in aged Alzheimer's transgenic mice despite stable beta-amyloid deposition. Neuroreport. 2004;15:1751–1754
  5. Ashe KH. Learning and memory in transgenic mice modeling Alzheimer's disease. Learn. Mem. 2001;8:301–308
  6. Baddeley A. Working Memory. Oxford: Oxford Press; 1986;
  7. Bliwise DL, Swan GE. Habitual napping and performance on the Trail Making Test. J. Sleep Res. 2005;14:209–210
  8. Braak H, Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol. Aging. 1995;16:271–278(discussion 8–84)
  9. Cave CB, Squire LR. Intact verbal and nonverbal short-term memory following damage to the human hippocampus. Hippocampus. 1992;2:151–163
  10. Chapman PF, White GL, Jones MW, Cooper-Blacketer D, Marshall VJ, Irizarry M, et al. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat. Neurosci. 1999;2:271–276
  11. Chong MS, Sahadevan S. Preclinical Alzheimer's disease: diagnosis and prediction of progression. Lancet Neurol. 2005;4:576–579
  12. Davies P, Maloney AJ. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet. 1976;2:1403
  13. DeKosky ST, Scheff SW. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann. Neurol. 1990;27:457–464
  14. DeKosky ST, Harbaugh RE, Schmitt FA, Bakay RA, Chui HC, Knopman DS, et al. Cortical biopsy in Alzheimer's disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Intraventricular Bethanecol Study Group. Ann. Neurol. 1992;32:625–632
  15. Devanand DP, Michaels-Marston KS, Liu X, Pelton GH, Padilla M, Marder K, et al. Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. Am. J. Psychiatry. 2000;157:1399–1405
  16. Dong H, Csernansky CA, Martin MV, Bertchume A, Vallera D, Csernansky JG. Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer's disease. Psychopharmacology (Berl). 2005;181:145–152
  17. Dudchenko PA, Wood ER, Eichenbaum H. Neurotoxic hippocampal lesions have no effect on odor span and little effect on odor recognition memory but produce significant impairments on spatial span, recognition, and alternation. J. Neurosci. 2000;20:2964–2977
  18. Fodero LR, Saez-Valero J, McLean CA, Martins RN, Beyreuther K, Masters CL, et al. Altered glycosylation of acetylcholinesterase in APP (SW) Tg2576 transgenic mice occurs prior to amyloid plaque deposition. J. Neurochem. 2002;81:441–448
  19. Fortin NJ, Agster KL, Eichenbaum HB. Critical role of the hippocampus in memory for sequences of events. Nat. Neurosci. 2002;5:458–462
  20. Gerlai R, Clayton NS. Analysing hippocampal function in transgenic mice: an ethological perspective. Trends Neurosci. 1999;22:47–51
  21. Gilbert PE, Barr PJ, Murphy C. Differences in olfactory and visual memory in patients with pathologically confirmed Alzheimer's disease and the Lewy body variant of Alzheimer's disease. J. Int. Neuropsychol. Soc. 2004;10:835–842
  22. Herholz K, Weisenbach S, Kalbe E, Diederich NJ, Heiss WD. Cerebral acetylcholine esterase activity in mild cognitive impairment. Neuroreport. 2005;16:1431–1434
  23. Holcomb LA, Gordon MN, Jantzen P, Hsiao K, Duff K, Morgan D. Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits. Behav. Genet. 1999;29:177–185
  24. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science. 1996;274:99–102
  25. Jacobsen JS, Wu CC, Redwine JM, Comery TA, Arias R, Bowlby M, et al. Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 2006;103:5161–5166
  26. Jankowsky JL, Xu G, Fromholt D, Gonzales V, Borchelt DR. Environmental enrichment exacerbates amyloid plaque formation in a transgenic mouse model of Alzheimer disease. J. Neuropathol. Exp. Neurol. 2003;62:1220–1227
  27. Kawarabayashi T, Younkin LH, Saido TC, Shoji M, Ashe KH, Younkin SG. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J. Neurosci. 2001;21:372–381
  28. Kesner RP, Gilbert PE, Barua LA. The role of the hippocampus in memory for the temporal order of a sequence of odors. Behav. Neurosci. 2002;116:286–290
  29. King DL, Arendash GW, Crawford F, Sterk T, Menendez J, Mullan MJ. Progressive and gender-dependent cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease. Behav. Brain Res. 1999;103:145–162
  30. Lane RM, Kivipelto M, Greig NH. Acetylcholinesterase and its inhibition in Alzheimer disease. Clin. Neuropharmacol. 2004;27:141–149
  31. Lazarov O, Robinson J, Tang YP, Hairston IS, Korade-Mirnics Z, Lee VM, et al. Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell. 2005;120:701–713
  32. Lehman EJ, Kulnane LS, Lamb BT. Alterations in beta-amyloid production and deposition in brain regions of two transgenic models. Neurobiol. Aging. 2003;24:645–653
  33. Levy DA, Manns JR, Hopkins RO, Gold JJ, Broadbent NJ, Squire LR. Impaired visual and odor recognition memory span in patients with hippocampal lesions. Learn. Mem. 2003;10:531–536
  34. Levy DA, Hopkins RO, Squire LR. Impaired odor recognition memory in patients with hippocampal lesions. Learn. Mem. 2004;11:794–796
  35. Li L, Tang BL. Environmental enrichment and neurodegenerative diseases. Biochem. Biophys. Res. Commun. 2005;334:293–297
  36. Moechars D, Lorent K, De Strooper B, Dewachter I, Van Leuven F. Expression in brain of amyloid precursor protein mutated in the alpha-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice. EMBO J. 1996;15:1265–1274
  37. Moechars D, Gilis M, Kuiperi C, Laenen I, Van Leuven F. Aggressive behaviour in transgenic mice expressing APP is alleviated by serotonergic drugs. Neuroreport. 1998;9:3561–3564
  38. Ohno M, Sametsky EA, Younkin LH, Oakley H, Younkin SG, Citron M, et al. BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease. Neuron. 2004;41:27–33
  39. Patel NV, Gordon MN, Connor KE, Good RA, Engelman RW, Mason J, et al. Caloric restriction attenuates Abeta-deposition in Alzheimer transgenic models. Neurobiol. Aging. 2005;26:995–1000
  40. Perry EK, Perry RH, Blessed G, Tomlinson BE. Changes in brain cholinesterases in senile dementia of Alzheimer type. Neuropathol. Appl. Neurobiol. 1978;4:273–277
  41. Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br. Med. J. 1978;2:1457–1459
  42. Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N. Engl. J. Med. 2005;352:2379–2388
  43. Samuel W, Terry RD, DeTeresa R, Butters N, Masliah E. Clinical correlates of cortical and nucleus basalis pathology in Alzheimer dementia. Arch. Neurol. 1994;51:772–778
  44. Simard M, van Reekum R. Memory assessment in studies of cognition-enhancing drugs for Alzheimer's disease. Drugs Aging. 1999;14:197–230
  45. Slotnick B. Animal cognition and the rat olfactory system. Trends Cogn. Sci. 2001;5:216–222
  46. Tabert MH, Liu X, Doty RL, Serby M, Zamora D, Pelton GH, et al. A 10-item smell identification scale related to risk for Alzheimer's disease. Ann. Neurol. 2005;58:155–160
  47. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 1991;30:572–580
  48. Turchi J, Sarter M. Cortical cholinergic inputs mediate processing capacity: effects of 192 IgG-saporin-induced lesions on olfactory span performance. Eur. J. Neurosci. 2000;12:4505–4514
  49. Vargha-Khadem F, Gadian DG, Watkins KE, Connelly A, Van Paesschen W, Mishkin M. Differential effects of early hippocampal pathology on episodic and semantic memory. Science. 1997;277:376–380
  50. Vosshall LB. Social signals: the secret language of mice. Curr. Biol. 2005;15:R255–R257
  51. Wisor JP, Edgar DM, Yesavage J, Ryan HS, McCormick CM, Lapustea N, et al. Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer's disease: a role for cholinergic transmission. Neuroscience. 2005;131:375–385
  52. Young JW, Finlayson K, Spratt C, Marston HM, Crawford N, Kelly JS, et al. Nicotine improves sustained attention in mice: evidence for involvement of the alpha7 nicotinic acetylcholine receptor. Neuropsychopharmacology. 2004;29:891–900
  53. Young JW, Crawford N, Kelly JS, Kerr LE, Marston HM, Spratt C, et al. Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice. Eur. Neuropsychopharmacol. 2007;17:145–155
  54. Young JW, Kerr LE, Kelly JS, Marston HM, Spratt C, Finlayson K, et al. The odour span task: a novel paradigm for assessing working memory in mice. Neuropharmacology. 2007;52:634–645

PII: S0197-4580(07)00451-4

doi: 10.1016/j.neurobiolaging.2007.11.018

Neurobiology of Aging
Volume 30, Issue 9 , Pages 1430-1443 , September 2009

Article Tools

* Image Usage & Resolution